National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI

Clinical Trial Results

Summaries of Newsworthy Clinical Trial Results

< Back to Main

Page Options
Print This Page  Print This Page
E-Mail This Document  E-Mail This Document
Browse by Cancer Type
Breast Cancer

Lung Cancer

Prostate Cancer

More Results
Search Trial Results

Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Información en español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

Denosumab May Help Prevent Bone Loss

Past Highlights
Related Pages
Prostate Cancer Home Page
NCI's gateway for information about prostate cancer.

Search for Clinical Trials
NCI's PDQ® registry of cancer clinical trials.
Prostate Cancer Trial Results
1.  Studies Make Case for Finasteride to Prevent Prostate Cancer
(Posted: 06/24/2008) - Three new analyses of data from a large prostate cancer prevention trial bolster the case for finasteride as a preventive agent against prostate cancer, according to an article published online May 18, 2008, by the journal Cancer Prevention Research.

2.  Comorbidities May Limit Benefits of Combination Prostate Therapy
(Posted: 01/30/2008) - Men with localized prostate cancer who are also ill with other disorders may suffer more from the negative side effects of anticancer treatments such as androgen suppression therapy, according to the Jan. 23, 2008, Journal of the American Medical Association.

3.  Finasteride Not Linked to High-Grade Prostate Cancers
(Posted: 09/12/2007) - Finasteride is unlikely to induce high-grade prostate cancers in men who take the drug to prevent the disease, according to two studies released online Sept. 11, 2007, by the Journal of the National Cancer Institute.

4.  Gabapentin Helps Hot Flashes From Prostate Cancer Treatment
(Posted: 06/20/2007) - The drug gabapentin (Neurontin®) effectively reduced the intensity and duration of hot flashes in a clinical trial of more than 200 men receiving hormonal treatment for their prostate cancer, according to findings presented at the 2007 ASCO meeting in Chicago.

5.  Post-Surgery Radiation of Some Benefit in Advanced Prostate Cancer
(Posted: 12/06/2006) - For men with advanced prostate cancer, radiation treatment after surgery can reduce the risk of recurrence by about 50 percent, though it does not help them live any longer, according to the Nov. 15, 2006, Journal of the American Medical Association.
1 2 3 4   Next >

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health